SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Peptides derived from proteolytic processing of the beta-amyloid precursor protein (APP), including the amyloid-beta peptide, are important for the pathogenesis of Alzheimer's dementia. We found that transgenic mice overexpressing APP have a profound and selective impairment in endothelium-dependent regulation of the neocortical microcirculation. Such endothelial dysfunction was not found in transgenic mice expressing both APP and superoxide dismutase-1 (SOD1) or in APP transgenics in which SOD was topically applied to the cerebral cortex. These cerebrovascular effects of peptides derived from APP processing may contribute to the alterations in cerebral blood flow and to neuronal dysfunction in Alzheimer's dementia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is a potent vasoconstrictor113,114 and suppresses endothelium-dependent responses, functional hyperemia, and cerebrovascular autoregulation.115–117”
In the citing paper
“Converging evidence suggests that amyloid-β and tau-related pathology contribute to chronic hypoperfusion of white matter tissue (Iadecola et al., 1999; Park et al., 2008).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Iadecola et al., 1999
In the citing paper
“Through these additional substrates, BACE1 has been implicated in inflammation, cardiovascular function, glucose homeostasis, and insulin signaling”
From BACE1: More than just a β‐secretase (2022) · cites this paper as [37]
In the citing paper
“The vascular alterations induced by Aβ are abrogated by overexpression of the ROS scavenging enzyme superoxide dismutase or deficiency of the NADPH oxidase subunit NOX2 (Iadecola et al., 1999; Park et al., 2005; 2008)”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Iadecola et al., 1999
In the citing paper
“overexpression of SOD1 in APP-overexpressing mice abolishes the lethal effects of the APP overexpression (40, 26).”
From Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes (2019) · cites this paper as [26]
Citations
Cites
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Self-citationA Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Wong, P. C., Pardo, C. A., Borchelt, D. R., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,445
Self-citationHensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
Mattson, M. P. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1081 · Cited by 1,006
Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels
FARACI, F. M., & HEISTAD, D. D. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.53 · Cited by 780
β-Amyloid-mediated vasoactivity and vascular endothelial damage
Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703
The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)
Multhaup, G., Schlicksupp, A., Hesse, L., Beher, D., Ruppert, T., Masters, C. L., & Beyreuther, K. (1996) · Science · doi:10.1126/science.271.5254.1406 · Cited by 678
Research works printed but not linked: 1
- Stamler, J. S. A radical vascular connection. Nature 380, 108–111 (1996).
Cited by
Items 101–200 of 420
Endothelial nitric oxide deficiency promotes Alzheimer’s disease pathology
Austin, S. A., Santhanam, A. V., Hinton, D. J., Choi, D., & Katusic, Z. S. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12334 · Cited by 155
Role of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease
Dickstein, D. L., Walsh, J., Brautigam, H., Stockton, S. D., Gandy, S., & Hof, P. R. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20155 · Cited by 155
Hooijmans, C. R., Rutters, F., Dederen, P. J., Gambarota, G., Veltien, A., van Groen, T., Broersen, L. M., Lütjohann, D., Heerschap, A., Tanila, H., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.06.007 · Cited by 154
Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade
Honjo, K., Black, S. E., & Verhoeff, N. P. L. G. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100015547 · Cited by 152
Tong, X.-K., Nicolakakis, N., Kocharyan, A., & Hamel, E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4031-05.2005 · Cited by 152
Scuteri, A., Nilsson, P. M., Tzourio, C., Redon, J., & Laurent, S. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328347cc17 · Cited by 151
New Therapeutic Targets in the Neurovascular Pathway in Alzheimer's Disease
Zlokovic, B. V. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.011 · Cited by 151
Oxidative damage in age-related macular degeneration.
Shen, J., Dong, A., Hackett, S. F., Bell, W. R., Green, W. R., & Campochiaro, P. A. (2007) · PubMed · doi:10.14670/hh-22.1301 · Cited by 150
Girouard, H., Park, L., Anrather, J., Zhou, P., & Iadecola, C. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000205849.22807.6e · Cited by 150
Self-citationCholinergic modulation of the cortical microvascular bed
Hamel, É. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45012-7 · Cited by 148
Christie, R. H., Yamada, M., Moskowitz, M. A., & Hyman, B. T. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64053-9 · Cited by 147
Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice
Schuessel, K., Schäfer, S., Bayer, T. A., Czech, C., Pradier, L., Müller-Spahn, F., Müller, W. E., & Eckert, A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.003 · Cited by 146
Li, J., Li, M., Ge, Y., Chen, J., Ma, J., Wang, C., Sun, M., Wang, L., Yao, S., & Yao, C. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00807-5 · Cited by 140
Why is the amyloid beta peptide of Alzheimer’s disease neurotoxic?
Rauk, A. (2008) · Dalton Transactions · doi:10.1039/b718601k · Cited by 139
Park, L., Wang, G., Moore, J., Girouard, H., Zhou, P., Anrather, J., & Iadecola, C. (2014) · Nature Communications · doi:10.1038/ncomms6318 · Cited by 139
Self-citationHan, B. H., Zhou, M.-L., Abousaleh, F., Brendza, R. P., Dietrich, H. H., Koenigsknecht-Talboo, J., Cirrito, J. R., Milner, E., Holtzman, D. M., & Zipfel, G. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4686-08.2008 · Cited by 138
Aliev, G., Priyadarshini, M., Reddy, V., Grieg, N. H., Kaminsky, Y., Cacabelos, R., Ashraf, G., Jabir, N. R., Kamal, M. A., Nikolenko, V. N., et al. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131227161303 · Cited by 138
“Interestingly, the superoxide scavenger, SOD, reversed the cerebrovascular effects caused by A 1-40 [58, 59].”
BackgroundInfluentialCapone, C., Faraco, G., Park, L., Cao, X., Davisson, R. L., & Iadecola, C. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00679.2010 · Cited by 136
Self-citationOngali, B., Nicolakakis, N., Tong, X.-K., Aboulkassim, T., Papadopoulos, P., Rosa-Neto, P., Lecrux, C., Imboden, H., & Hamel, E. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.018 · Cited by 134
Cerebral Amyloid Angiopathy and Vessel Dysfunction
Greenberg, S. M. (2002) · Cerebrovascular Diseases · doi:10.1159/000049149 · Cited by 134
IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation
Gunnett, C. A., Heistad, D. D., Berg, D., & Faraci, F. M. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.4.h1555 · Cited by 134
Amyloid-beta and tau protein beyond Alzheimer’s disease
Abyadeh, M., Gupta, V., Paulo, J. A., Mahmoudabad, A. G., Shadfar, S., Mirshahvaladi, S., Gupta, V. B., Nguyen, C. T. O., Finkelstein, D. I., You, Y., et al. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.386406 · Cited by 133
Han, B. H., Zhou, M.-L., Johnson, A. W., Singh, I., Liao, F., Vellimana, A. K., Nelson, J. W., Milner, E., Cirrito, J. R., Basak, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414930112 · Cited by 131
Dietary nitrate supplementation improves sprint and high-intensity intermittent running performance
Thompson, C., Vanhatalo, A., Jell, H., Fulford, J., Carter, J., Nyman, L., Bailey, S. J., & Jones, A. M. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.10.006 · Cited by 130
“NO is pivotal to a number of cerebral processes including neurotransmission, vasodilation and neurovascular coupling (Aamand et al. 2013; Iadecola et al. 1999; Piknova et al. 2011; Rifkind et al. 2007).”
BackgroundInnate immunity receptor CD36 promotes cerebral amyloid angiopathy
Park, L., Zhou, J., Zhou, P., Pistick, R., El Jamal, S., Younkin, L., Pierce, J., Arreguin, A., Anrather, J., Younkin, S. G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300021110 · Cited by 130
Self-citationXu, J., Chen, S., Ku, G., Ahmed, S. H., Xu, J., Chen, H., & Hsu, C. Y. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200106000-00008 · Cited by 128
Age-Dependent Neurovascular Dysfunction and Damage in a Mouse Model of Cerebral Amyloid Angiopathy
Park, L., Koizumi, K., El Jamal, S., Zhou, P., Previti, M. L., Van Nostrand, W. E., Carlson, G., & Iadecola, C. (2014) · Stroke · doi:10.1161/strokeaha.114.005179 · Cited by 128
Self-citationParis, D., Humphrey, J., Quadros, A., Patel, N., Crescentini, R., Crawford, F., & Mullan, M. (2003) · Neurological Research · doi:10.1179/016164103101201940 · Cited by 127
Park, L., Anrather, J., Forster, C., Kazama, K., Carlson, G. A., & Iadecola, C. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000105800.49957.1e · Cited by 127
Self-citationCauses and consequences of baseline cerebral blood flow reductions in Alzheimer’s disease
Bracko, O., Cruz Hernández, J. C., Park, L., Nishimura, N., & Schaffer, C. B. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20982383 · Cited by 124
Tong, X.-K., Nicolakakis, N., Fernandes, P., Ongali, B., Brouillette, J., Quirion, R., & Hamel, E. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.003 · Cited by 122
The Role of Pericytes in Neurovascular Unit Remodeling in Brain Disorders
ElAli, A., Thériault, P., & Rivest, S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046453 · Cited by 122
Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations
Koizumi, K., Wang, G., & Park, L. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0256-9 · Cited by 118
Novel isoforms of NADPH-oxidase in cerebral vascular control
Miller, A. A., Drummond, G. R., & Sobey, C. G. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.02.005 · Cited by 118
Cerebral autoregulation in Alzheimer's disease
Claassen, J. A. H. R., & Zhang, R. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.69 · Cited by 117
High-Density Lipoproteins and Cerebrovascular Integrity in Alzheimer’s Disease
Stukas, S. K., Robert, J., & Wellington, C. L. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.003 · Cited by 112
Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?
Silva, T. M. D., & Miller, A. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00061 · Cited by 112
Type 2 diabetes mellitus, dyslipidemia, and Alzheimer’s disease
Carlsson, C. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100012 · Cited by 109
“Both Aβ deposition and cerebrovascular dysregulation are two early findings in preclinical AD pathology [50,51] and work synergistically to accelerate neuronal degeneration [7] (Fig.”
Nikolakopoulou, A. M., Zhao, Z., Montagne, A., & Zlokovic, B. V. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176225 · Cited by 109
BACE1: More than just a β‐secretase
Taylor, H. A., Przemylska, L., Clavane, E. M., & Meakin, P. J. (2022) · Obesity Reviews · doi:10.1111/obr.13430 · Cited by 107
“sAPPβ causes ER stress, inflammation and insulin resistance Aβ and APP overexpression induce endothelial dysfunction.(37) Aβ levels in human plasma correlate with vascular function and diabetes.”
BackgroundCapone, C., Faraco, G., Peterson, J. R., Coleman, C., Anrather, J., Milner, T. A., Pickel, V. M., Davisson, R. L., & Iadecola, C. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6262-11.2012 · Cited by 106
“Agents were applied at concentrations previously determined not to be supramaximal (Iadecola et al., 1999).”
BackgroundMethodSelf-citationCerebral blood flow regulation by nitric oxide in neurological disorders
Toda, N., Ayajiki, K., & Okamura, T. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-048 · Cited by 106
Extra-virgin olive oil for potential prevention of Alzheimer disease
Román, G. C., Jackson, R. E., Reis, J. J., Roman, A., Toledo, J. B., & Toledo, E. (2019) · Revue Neurologique · doi:10.1016/j.neurol.2019.07.017 · Cited by 106
Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease
Hamel, E., Nicolakakis, N., Aboulkassim, T., Ongali, B., & Tong, X. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.038729 · Cited by 103
Angiotensin II attenuates functional hyperemia in the mouse somatosensory cortex
Kazama, K., Wang, G., Frys, K., Anrather, J., & Iadecola, C. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00464.2003 · Cited by 105
Self-citationDidion, S. P., Lynch, C. M., Baumbach, G. L., & Faraci, F. M. (2005) · Stroke · doi:10.1161/01.str.0000152952.42730.92 · Cited by 103
Transgenic mouse models of Alzheimer’s disease
Janus, C., Chishti, M. A., & Westaway, D. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00033-8 · Cited by 101
Compromised Hemodynamic Response in Amyloid Precursor Protein Transgenic Mice
Mueggler, T., Sturchler-Pierrat, C., Baumann, D., Rausch, M., Staufenbiel, M., & Rudin, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07218.2002 · Cited by 101
Lana, D., Ugolini, F., & Giovannini, M. G. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.585833 · Cited by 100
Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated
Brickman, A. M., Guzman, V. A., Gonzalez-Castellon, M., Razlighi, Q., Gu, Y., Narkhede, A., Janicki, S., Ichise, M., Stern, Y., Manly, J. J., et al. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.03.005 · Cited by 99
Cerebral Hypoperfusion, Capillary Degeneration, and Development of Alzheimer Disease
de la Torre, J. C. (2000) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200000001-00012 · Cited by 100
Chapter 14 Cerebral vascular dysregulation in the ischemic brain
(2008) · Handbook of Clinical Neurology · doi:10.1016/s0072-9752(08)01914-3 · Cited by 98
Self-citationThe reflection of Alzheimer disease in CSF.
Spies, P. E. (2012) · Radboud Repository (Radboud University) · Cited by 98
The X11 proteins, Aβ production and Alzheimer's disease
Miller, C. C. J., McLoughlin, D. M., Lau, K.-F., Tennant, M. E., & Rogelj, B. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.03.001 · Cited by 97
Cerebrovascular Effects of Amyloid-ß Peptides: Mechanisms and Implications for Alzheimer's Dementia
Iadecola, C. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025092617651 · Cited by 97
Self-citationIs Vasomotion in Cerebral Arteries Impaired in Alzheimer’s Disease?
Di Marco, L. Y., Farkas, E., Martin, C., Venneri, A., & Frangi, A. F. (2015) · Journal of Alzheimer's Disease · doi:10.3233/jad-142976 · Cited by 95
Dieter, H. H., Bayer, T. A., & Multhaup, G. (2005) · Acta hydrochimica et hydrobiologica · doi:10.1002/aheh.200400556 · Cited by 95
Zhang, L., Papadopoulos, P., & Hamel, E. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12315 · Cited by 94
Mechanisms of Soluble β-Amyloid Impairment of Endothelial Function
Gentile, M. T., Vecchione, C., Maffei, A., Aretini, A., Marino, G., Poulet, R., Capobianco, L., Selvetella, G., & Lembo, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407358200 · Cited by 92
Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice
Schilling, G., Savonenko, A. V., Coonfield, M. L., Morton, J. L., Vorovich, E. B., Gale, A., Neslon, C., Chan, N., Eaton, M., Fromholt, D., et al. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.003 · Cited by 92
Self-citationInterleukin-10 Protects Nitric Oxide–Dependent Relaxation During Diabetes
Gunnett, C. A., Heistad, D. D., & Faraci, F. M. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1931 · Cited by 91
Didion, S. P., & Faraci, F. M. (2003) · Stroke · doi:10.1161/01.str.0000081225.46324.aa · Cited by 90
Superoxide dismutase 1 protects retinal cells from oxidative damage
Dong, A., Shen, J., Krause, M., Akiyama, H., Hackett, S. F., Lai, H. C., & Campochiaro, P. A. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20683 · Cited by 89
Vascular Biology in Genetically Altered Mice: Smaller Vessels, Bigger Insight
Faraci, F. M., & Sigmund, C. D. (1999) · Circulation Research · doi:10.1161/01.res.85.12.1214 · Cited by 87
Claassen, J. A. H. R., & Jansen, R. W. M. M. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.3.267 · Cited by 86
The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease
Pimentel‐Coelho, P. M., & Rivest, S. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08126.x · Cited by 85
Kinetics of Cerebral Amyloid Angiopathy Progression in a Transgenic Mouse Model of Alzheimer Disease
Robbins, E. M., Betensky, R. A., Domnitz, S. B., Purcell, S. M., Garcia-Alloza, M., Greenberg, C., Rebeck, G. W., Hyman, B. T., Greenberg, S. M., Frosch, M. P., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3854-05.2006 · Cited by 84
Gsell, W., de Sadeleer, C., Marchalant, Y., MacKenzie, E. T., Schumann‐Bard, P., & Dauphin, F. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00095-8 · Cited by 83
Imaging of cerebrovascular pathology in animal models of Alzheimer's disease
Klohs, J., Rudin, M., Shimshek, D. R., & Beckmann, N. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00032 · Cited by 82
“…demonstrated alterations in vasoactive signaling (Niwa et al., 2001) and in the renin-angiotensin system (Takeda et al., 2009), as well as the generation of reactive oxygen species (Iadecola et al., 1999; Tong et al., 2005) in the brains of APP mice, all of which can directly affect vascular tone.”
BackgroundDynamic Regulation of Cerebral Blood Flow in Patients With Alzheimer Disease
de Heus, R. A. A., de Jong, D. L. K., Sanders, M. L., van Spijker, G. J., Oudegeest-Sander, M. H., Hopman, M. T., Lawlor, B. A., Olde Rikkert, M. G. M., & Claassen, J. A. H. R. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.10900 · Cited by 82
Superoxide levels and function of cerebral blood vessels after inhibition of CuZn-SOD
Didion, S. P., Hathaway, C. A., & Faraci, F. M. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.4.h1697 · Cited by 82
Microvascular Alterations in Alzheimer's Disease
Steinman, J., Sun, H.-S., & Feng, Z.-P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.618986 · Cited by 81
Imaging the role of blood–brain barrier disruption in normal cognitive ageing
Verheggen, I. C. M., de Jong, J. J. A., van Boxtel, M. P. J., Postma, A. A., Jansen, J. F. A., Verhey, F. R. J., & Backes, W. H. (2020) · GeroScience · doi:10.1007/s11357-020-00282-1 · Cited by 81
Stefani, A., Sancesario, G., Pierantozzi, M., Leone, G., Galati, S., Hainsworth, A. H., & Diomedi, M. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.343 · Cited by 80
Uekawa, K., Hattori, Y., Ahn, S. J., Seo, J., Casey, N., Anfray, A., Zhou, P., Luo, W., Anrather, J., Park, L., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00660-1 · Cited by 80
Self-citationPrice, J. M., Chi, X., Hellermann, G., & Sutton, E. T. (2001) · Neurological Research · doi:10.1179/016164101101198758 · Cited by 80
Hypertension and Cognitive Function
Obisesan, T. O. (2009) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2009.03.002 · Cited by 79
Paris, D., Quadros, A., Humphrey, J., Patel, N. S., Crescentini, R. M., Crawford, F., & MULLAN, M. J. (2004) · Brain Research · doi:10.1016/j.brainres.2003.11.061 · Cited by 79
Royea, J., Zhang, L., Tong, X.-K., & Hamel, E. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0329-17.2017 · Cited by 78
Altered microglia and neurovasculature in the Alzheimer's disease cerebellum
Singh‐Bains, M. K., Linke, V., Austria, M. D. R., Tan, A. Y. S., Scotter, E. L., Mehrabi, N. F., Faull, R. L. M., & Dragunow, M. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104589 · Cited by 78
The amyloid precursor protein of Alzheimer disease in human brain and blood
Li, Q.-X., Fuller, S. J., Beyreuther, K., & Masters, C. L. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.4.567 · Cited by 77
Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention
Miller, A. A., Budzyn, K., & Sobey, C. G. (2010) · Clinical Science · doi:10.1042/cs20090649 · Cited by 77
Proinflammatory and Vasoactive Effects of Aβ in the Cerebrovasculature
TOWNSEND, K. P., OBREGON, D., QUADROS, A., PATEL, N., VOLMAR, C., PARIS, D., & MULLAN, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04799.x · Cited by 76
Barkats, M., Millecamps, S., Abrioux, P., Geoffroy, M., & Mallet, J. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751438.x · Cited by 75
The role of inflammatory processes in Alzheimer’s disease
Broussard, G. J., Mytar, J. O., Li, R., & Klapstein, G. J. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0130-z · Cited by 74
Emerging Roles of Endothelial Nitric Oxide in Preservation of Cognitive Health
Katusic, Z. S., d’Uscio, L. V., & He, T. (2023) · Stroke · doi:10.1161/strokeaha.122.041444 · Cited by 73
Kim, H. A., Miller, A. A., Drummond, G. R., Thrift, A. G., Arumugam, T. V., Phan, T. G., Srikanth, V. K., & Sobey, C. G. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0790-7 · Cited by 72
Bär, K.-J., Boettger, M. K., Seidler, N., Mentzel, H. J., Terborg, C., & Sauer, H. (2007) · Stroke · doi:10.1161/strokeaha.107.492033 · Cited by 71
Drouin, A., Bolduc, V., Thorin‐Trescases, N., Bélanger, É., Fernandes, P., Baraghis, E., Lesage, F., Gillis, M., Villeneuve, L. R., Hamel, É., et al. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00410.2010 · Cited by 71
Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway
Paris, D., Town, T., Mori, T., Parker, T. A., Humphrey, J., & MULLAN, M. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00111-6 · Cited by 71
Didion, S. P., Kinzenbaw, D. A., & Faraci, F. M. (2005) · Hypertension · doi:10.1161/01.hyp.0000187532.80697.15 · Cited by 68
Capone, C., Faraco, G., Anrather, J., Zhou, P., & Iadecola, C. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.145813 · Cited by 61
Self-citationAmyloid-Beta Peptide Is Toxic to Neurons In Vivo via Indirect Mechanisms
Walsh, D. T., Montero, R. M., Bresciani, L. G., Jen, A. Y. T., Leclercq, P. D., Saunders, D., EL-Amir, A. N., Gbadamoshi, L., Gentleman, S. M., & Jen, L.-S. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0485 · Cited by 66
Ongali, B., Nicolakakis, N., Lecrux, C., Aboulkassim, T., Rosa‐Neto, P., Papadopoulos, P., Tong, X., & Hamel, É. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100339 · Cited by 66
Vascular and Metabolic Factors in Alzheimer’s Disease and Related Dementias: Introduction
Iadecola, C. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0319-y · Cited by 66
Self-citationTong, X., & Hamel, É. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.226 · Cited by 65
Progression of Cerebral Amyloid Angiopathy in Transgenic Mouse Models of Alzheimer Disease
Domnitz, S. B., Robbins, E. M., Hoang, A. W., Garcia-Alloza, M., Hyman, B. T., Rebeck, G. W., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000171644.00180.fc · Cited by 67
CD40 signaling and Alzheimer's disease pathogenesis
Town, T., Tan, J., & MULLAN, M. J. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00044-4 · Cited by 65
Oxidative Damage to the c‐fos Gene and Reduction of Its Transcription After Focal Cerebral Ischemia
Cui, J., Holmes, E. H., & Liu, P. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731164.x · Cited by 64
Small vessels, dementia and chronic diseases – molecular mechanisms and pathophysiology
Horsburgh, K., Wardlaw, J. M., van Agtmael, T., Allan, S. M., Ashford, M. L. J., Bath, P. M., Brown, R., Berwick, J., Cader, M. Z., Carare, R. O., et al. (2018) · Clinical Science · doi:10.1042/cs20171620 · Cited by 63
Metadata
- Authors
- Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K., & Carlson, G. A.
- Affiliations
- University of Minnesota (US)
- Mayo Clinic (US)
- McLaughlin Research Institute (US)
- National Institutes of Health (US)
- Johns Hopkins University (US)
- Corresponding author
- Iadecola, Costantino
- ORCID
- Venue
- Nature Neuroscience
- Published
- 1999-02
- Volume
- 2
- Issue
- 2
- Pages
- 157-161
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- DOI
- 10.1038/5715
- OpenAlex
- W1525061277
- Cited by
- 399
- References
- 46
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 6 · 2023: 10 · 2022: 8 · 2021: 12 · 2020: 16 · 2019: 17 · 2018: 10 · 2017: 11 · 2016: 16 · 2015: 18 · 2014: 19 · 2013: 18 · 2012: 18
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS-37853, R01NS035806, NS34179, NS-35806, R01NS037853)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- superoxide dismutase 1, amyloid precursor protein, APP overexpression, cerebral microcirculation, Alzheimer's disease, amyloid-beta, cerebral blood flow, neocortex, transgenic mice
- MeSH terms
- Superoxide Dismutase-1, Animals, Cerebral Cortex, Cerebrovascular Circulation, Endothelium, Vascular, Humans, Mice, Transgenic, Superoxide Dismutase, Vasoconstrictor Agents, Free Radical Scavengers, Amyloid beta-Protein Precursor, 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.